Sentence examples for incremental costs would be from inspiring English sources

If we only include the subset of patients with at least 5 years of followup, the incremental costs would be $7,540, consistent with the estimates from Li et al. Second, Li et al. only examined newly active SLE patients, while we included both incident and prevalent SLE patients.

In addition, if half of all outpatients used smartcards to pay their invoices, along with four cashier windows for cash payments, then the waiting time of cash service users could be reduced by approximately 3 minutes and the incremental cost would be close to breaking even (even though it has a higher overall unit cost that the traditional service).

"Over time," said Mr. Rogers, "the price of electricity per unit will go up, because there would be an incremental cost in adding efficiency equipment — although that cost would be less than the incremental cost of adding a new power plant.

Even if savings due to better prognosis were not included, as they rely on the resource consumption pattern estimated through the expert panel, the incremental cost-effectiveness ratios would be 29,400€ and 85€.

In the event of the intervention having higher costs and better outcomes, cost-effectiveness would be assessed using incremental cost-effectiveness ratios (ICERs).

If a higher intervention cost is assumed and advertising costs are similar to those observed in the txt2stop trial, then the incremental cost-effectiveness would be £141 per LY gained and £89 per QALY gained.

In the worst-case scenario, not accounting for sequelae such as late meniscal lesions or development of osteoarthritis, the incremental cost effectiveness would be 68,715 USD/QALY for surgical treatment.

Incremental drug costs per patient would be £3,712 (23% more than originally proposed) for pemetrexed and £1,840 11% less) for erlotinib.

With the replacement scenario, though, there will always be incremental costs due to infection control, which would be cost-effective (according to Dutch standards) when attributable mortality of MRSA is at least 21%.

The probability that MobileMums is cost-effective is given by the proportion of pairs of incremental costs and benefits at which the intervention would be considered cost-effective.

If TXA was associated with a 19% reduction in the probability of death (lower bound of the 95% confidence interval) the incremental cost of TXA would be $33 in Tanzania, $45 in India and $43 in the UK.